Our results demonstrated that this co-immunization vaccine suppressed the tumor development of multiple hepatocarcinoma by generating anti-tumor immune response via cytotoxic T cell provoked by CD8+CD11c+ DCs, suggesting that strengthening co-immunization could stimulate CD8+ T cell immune responses ideally. The gene discussed is ITGAX; the disease is neoplasm.